Related to this topic: Leaflets | Support | Patient+ | Diagrams | UK Guidelines | Online Videos | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Antibiotic Prophylaxis

Prevention of endocarditis in patients with heart-valve lesion, septal defect, patent ductus, prosthetic valve or history of endocarditis
  • Dental procedures under local or no anaesthesia.
    • This includes extractions, scaling, and surgery involving gingival tissues.
    • Patients who have not received a single dose of penicillin in the previous month (e.g. during multistage treatment), including those with a prosthetic valve (but excluding those who have had endocarditis), should have oral amoxicillin 3 g 1 hour before procedure
    • Children under 5 years should have a quarter adult dose, and 5-10 years half the adult dose.1 Patients who are penicillin-allergic or have received more than a single dose of a penicillin in the previous month, oral clindamycin is recommended 600 mg 1 hour before procedure.
    • Children under 5 years should have clindamycin 150 mg or azithromycin 200 mg.
    • Those between 5-10 years should be given clindamycin 300 mg or azithromycin 300 mg.
    • For multistage procedures a maximum of 2 single doses of a penicillin may be given in a month; alternative drugs should be used for further treatment and the penicillin should not be used again for 3-4 months.2
    • If clindamycin is used, it should not be repeated at intervals of less than two weeks for periodontal or other multistage procedures. Clindamycin is not licensed for use in endocarditis prophylaxis but is endorsed by the Endocarditis Working Party.1
    • For patients who have had endocarditis, give amoxicillin gentamicin, as per the guidance for general anaesthesia.
  • Dental procedures under general anaesthesia.3
    • Patients who do not have a prosthetic valve or who have not had endocarditis, (including patients who have not received more than a single dose of a penicillin in the previous month), should be given i/v amoxicillin 1 g at induction, followed by oral amoxicillin 500 mg 6 hours later.
    • Children under 5 years should be given a quarter of the adult dose, and those under 5-10 years half adult dose.
    • Another option is to give oral amoxicillin 3 g 4 hours before induction then oral amoxicillin 3 g as soon as possible after procedure (child under 5 years quarter adult dose; 5-10 years half adult dose).
    • Special risk patients (i.e.those with a prosthetic valve or who have had endocarditis), should be given i/v amoxicillin 1 g plus i/v gentamicin 120 mg at induction, then oral amoxicillin 500 mg 6 hours later. Children under 5 years should be given amoxicillin quarter adult dose, gentamicin 2 mg/kg, and those 5-10 years ,amoxicillin half adult dose, gentamicin 2 mg/kg.
    • Patients allergic to penicillin or who have had a single dose of penicillin in the preceding month should have either i/v vancomycin 1 g over at least 100 minutes then i/v gentamicin 120 mg at induction or 15 minutes before procedure.
    • Children under 10 years should be given vancomycin 20 mg/kg gentamicin 2 mg/kg.
    • Alternatives are i/v teicoplanin 400 mg plus gentamicin 120 mg at induction or 15 minutes before procedure.
    • For children under 14 years give teicoplanin 6 mg/kg plus gentamicin 2 mg/kg or i/v clindamycin 300 mg over at least 10 minutes at induction or 15 minutes before procedure.
    • This should be followed by oral or i/v clindamycin 150 mg 6 hours later (for child under 5 years quarter adult dose; 5-10 years half adult dose).
    • The situation regarding dental procedures and antibiotic prophylaxis is controversial subject. The lack of evidence to support guidelines has been questioned, and a Cochrane review advises clinicians to discuss the pros and cons of antibiotic prophylaxis with patients before prescribing.4
Prevention of recurrence of rheumatic fever5
  • The World Health Organisation (WHO) recommend secondary prophylaxis with oral phenoxymethylpenicillin 250 mg twice daily or sulfadiazine 1 g daily (500 mg daily for patients under 30 kg).2,6
  • However, a Cochrane meta-analysis suggests that two- or three-weekly injections of intramuscular penicillin works better.6
  • The duration of treatment is controversial. Many of the UK trials were done in the 1950s when rheumatic fever was more virulent and frequent than it is today, and many of the modern trials are done in countries where this situation still prevails. Some authorities believe prophylaxis should be lifelong. Others recommend this should only be continued for the first few years after an acute attack in patients under the age of 18, or for those who have sustained severe cardiac damage.7
Prevention of a secondary case of bacterial meningitis8
  • Rifampicin is recommended first line treatment:
    • 600 mg every 12 hours for 2 days for an adult
    • 10 mg/kg every 12 hours for 2 days for a child over 1 year
    • 5 mg/kg for a child under one year
  • Alternatives are:
    • Ciprofloxacin (unlicensed use) 500 mg as a single dose (child 5-12 years 250 mg)
    • I/m ceftriaxone (unlicensed use) 250 mg as a single dose (child under 12 years 125 mg)9

Systematic evidence is limited due to the ethics of not giving prophylaxis to a control sample, and there is therefore limited information as to which contacts to treat.10 Contact tracing is normally undertaken by local public health clinicians, and further guidance has been issued by the Health Protection Agency,10 as follows:

Prophylaxis indicated

Irrespective of vaccination status, chemoprophylaxis should be offered to the following individuals:

  • Those who have had prolonged close contact with the case in a household type setting during the seven days before onset of illness, e.g.
  • Those living and/or sleeping in the same accommodation
  • Pupils in the same dormitory
  • Boy/girlfriends
  • University students sharing a kitchen in a hall of residence
  • Those who have had transient close contact with a case only if they have been directly exposed to large particle droplets/secretions from the respiratory tract of a case around the time of admission to hospital (e.g. healthcare workers).

Prophylaxis not indicated

(unless already identified as close contact):

  • Staff and children attending same nursery or creche
  • Students/pupils in same school/class/tutor group
  • Work or school colleagues
  • Friends
  • Residents of nursing/residential homes
  • Kissing on cheek or mouth (intimate kissing would normally bring the contact into the close prolonged contact category)
  • Food or drink sharing or similar low level of salivary contact
  • Attending the same social function
  • Travelling in next seat on same plane, train, bus, or car
Prevention of a secondary case of Haemophilus influenza B

Rifampicin is recommended by the Department of Health11:

  • 600 mg once daily for 4 days (regimen of choice for adults)
  • Child 1-3 months 10 mg/kg once daily for 4 days
  • Over 3 months 20 mg/kg once daily for 4 days (max. 600 mg daily)
  • Should be given to all household contacts, irrespective of immunisation status, except for children under 4 who have been fully immunised
  • Should also be offered to all room contacts - teachers and children - if two cases occur in a playgroup, nursery or creche within 120 days11
Prevention of secondary case of diphtheria in non-immune patients
  • The Department of Health recommends erythromycin11:
    • For adults and children over 8 for 7 days 500 mg every 6 hours
    • For children 2-8 years 250 mg every 6 hours
    • Under 2 years 125 mg every 6 hours
    • The Green Book cites penicillin as another option
  • Diphtheria is still prevalent in parts of Asia, South America, Africa and India, and may well re-emerge in the UK if immunisation rates are not maintained.11
  • As well as antibiotic prophylaxis, partially or unimmunised individuals should complete immunisation according to the UK schedule.
  • Completely immunised individuals should receive a single reinforcing dose of a diphtheria-containing vaccine according to their age.11
Prevention of secondary case of pertussis in non-immune patient or partially immune patient
  • UK guidelines recommend erythromycin12:
    • Adults and children over 8 years, 250-500 mg every 6 hours for 7 days
    • Children 2-8 years use 250 mg every 6 hours
    • Under 2 years 125 mg every 6 hours
  • Evidence for antibiotic prophylaxis weak
  • Because of well-known side effects of erythromycin (mainly gastrointestinal), clinicians should take a cautious approach to prescribing
  • Prophylaxis should be offered to a household contact if :
    • A newborn baby or young infant
    • Any unimmunised member of their household
    • Contacts 5 years or over if they did not receive pre-school pertussis booster (not given to those born before 1996 in the UK).
    • No benefit in giving prophylaxis more than 21 days from the date of onset of the primary case. Unimmunised or partially immunised contacts should complete their course of vaccine.
Prevention of pneumococcal infection in asplenia or in patients with sickle cell disease
  • Evidence supports the use of phenoxymethylpenicillin:13,2
    • 500 mg every 12 hours for adults.
    • Children under 5 years use 125 mg every 12 hours
    • 6-12 years use 250 mg every 12 hours
    • If cover also needed for H. influenzae in a child give amoxicillin instead:
    • Under 5 years 125 mg every 12 hours
    • Over 5 years 250 mg every 12 hours)
  • Systematic evidence supports use of antibiotic prophylaxis, irrespective of immunisation status, from the age of four months.14
  • Erythromycin may be used for those allergic to penicillin, but effectiveness less well supported by evidence.15
  • One trial supported the cessation of prophylaxis at the age of five providing child had had at least two years of antibiotic, was fully immunised, and had had no episodes of pneumococcal infection or a splenectomy.
  • Parents should be counselled to report any febrile illness16
  • Similar considerations apply to splenectomised patients or patients with hyposplenia, irrespective of immune status
  • Evidence for stopping antibiotic prophylaxis less convincing, many experts advise continuing indefinitely
Upper respiratory tract procedures

As for dental procedures; post-operative dose may be given parenterally if swallowing is painful.2,17

Genito-urinary procedures

As for special risk patients undergoing dental procedures under general anaesthesia except that clindamycin is not given. If the urine infected, prophylaxis should also cover the infective organism.2

Obstetric, gynaecological and gastro-intestinal procedures

As for genito-urinary procedures, but only required for patients with prosthetic valves or those who have had endocarditis only.2

Joint prostheses and dental treatment
  • Patients with prosthetic joint implants (including total hip replacements) do not require antibiotic prophylaxis for dental treatment.
  • The evidence to support prophylaxis is lacking and there is no benefit in exposing patients to adverse effects.18
  • Intercurrent infection should be treated as appropriate.
  • The frequency of joint infection after dental treatment is extremely small, the risk of streptococcal infection even smaller.2
Dermatological procedures

Antibacterial prophylaxis against endocarditis is not required.1 However, this applies to surgery on clean skin. Prophylaxis should be considered if procedures on infected areas are carried out (e.g. treatment of wound infections) if the surgery cannot be postponed until the infection is treated.19

Immunosuppression and indwelling intraperitoneal catheters

Antibiotic prophylaxis is not required for patients having dental treatment who are immunosuppressed (including transplant patients and patients with indwelling intraperitoneal catheters), providing there is no other indication for prophylaxis. There is little evidence that such patients acquire infection after dental procedures.1

Prevention of gas-gangrene in high lower-limb amputations or following major trauma

Benzylpenicillin 300-600 mg should be given every 6 hours for 5 days. For penicillin-allergic patients, give metronidazole 400-500 mg every 8 hours.15,20

Prevention of tuberculosis in susceptible close contacts or those who have become tuberculin positive
  • The Joint Tuberculosis Committee recommends chemoprophylaxis for the following:21
    • Patients with documented recent tuberculin conversion
    • Tuberculin-positive children identified in BCG schools programme
    • Children under 2 years in close contact with smear-positive tuberculosis (including those previously vaccinated with BCG but now showing strongly positive tuberculin test)
    • Children under 16 years showing a positive tuberculin test at new immigrant or contact screening.
    • Chemoprophylaxis should also be considered for immigrant adults 16-34 years without a BCG scar but with strongly positive tuberculin test.
  • The BNF recommend a regime of isoniazid 300 mg daily for 6 months to adults 5-10 mg/kg daily (max. 300 mg daily) to children.
  • An alternative is isoniazid 300 mg daily rifampicin 600 mg daily (450 mg if less than 50 kg) for 3 months for adults and isoniazid 5-10 mg/kg daily (max. 300 mg daily) rifampicin 10 mg/kg daily (max. 600 mg daily) for children.
  • There is a risk of hepatotoxicity with isoniazid, but this is far outweighed by the risk of developing TB if prophylaxis is not given.22
Prevention of infection in gastro-intestinal procedures
  • Operations on stomach or oesophagus for carcinoma - The Scottish Intercollegiate Network Guidelines Network (SIGN) recommend antibiotics unless local guidelines specify exceptions.23 SIGN advise that the selection of antibiotics should be guided by local policy.
  • Additional intra-operative or postoperative doses of antibacterial may be given for prolonged procedures or if there is major blood loss.2
  • Open biliary surgery - the BNF recommends giving a single dose of i/v cefuroxime i/v metronidazole or i/v gentamicin i/v metronidazole.2
  • Metronidazole may be given by suppositories, two hours before surgery to allow absorption.
  • There appears to be no benefit in giving antibiotic prophylaxis prior to elective laparoscopic cholecystectomy.24
  • Resections of colon and rectum for carcinoma, and resections in inflammatory bowel disease, and appendicectomy - give a single dose of i/v gentamicin i/v metronidazole.
  • An alternative is i/v cefuroxime i/v metronidazole or i/v co-amoxiclav alone.2
  • There is considerable evidence to support the role of pre-operative antibiotics in the reduction of post-operative infections.25
  • Endoscopic retrograde cholangiopancreatography - a single dose of i/v gentamicin or oral or i/v ciprofloxacin is advised by the BNF.2
  • This is a controversial area, and some experts argue that increased infection control measures during the procedure would obviate the need for prophylaxis.26
  • Prophylaxis is however, particularly important if there is bile stasis, pancreatic pseudocyst, a history of cholangitis or neutropenia.2
Prevention of infection in urological procedures
  • Transrectal prostate biopsy - SIGN recommend prophylactic antibiotics.23 The BNF advise a single dose of i/v cefuroxime i/v metronidazole or i/v gentamicin.
  • Additional intra-operative or postoperative doses of antibacterial may be given for prolonged procedures or if there is major blood loss.
  • Metronidazole may be given in suppository form.2 There is an evidence base to support that there is a significant risk of infection without antibiotic cover has a significant risk of infection.27
Transurethral resection of prostate

SIGN advise the use of antibiotics as prophylaxis.23 The BNF recommend a single dose of oral ciprofloxacin or i/v gentamicin or i/v cefuroxime. There is a discussion in the literature about the benefit of various regimes28 and methods of delivery29 but no meta-analyses from which definitive guidance can be drawn.

Prevention of infection in obstetric and gynaecological surgery
  • Caesarean section - SIGN support the use of prophylactic antibiotics unless local policies identify exceptions.23 The BNF advises a single dose of i/v cefuroxime, administered immediately after the umbilical cord is clamped. If there is a history of penicillin or cephalosporin allergy, i/v clindamycin is an alternative.15 Again, there is a discussion in the literature about various regimes,30 and also about the timing of medication.31
  • Hysterectomy - SIGN recommend prophylaxis for both abdominal and vaginal procedures, unless local policies identify exceptions.23 The BNF recommend a single dose(1) of i/v cefuroxime i/v metronidazole(2) or i/v gentamicin i/v metronidazole(2) or i/v co-amoxiclav alone. There is some evidence that a two-dose regime is better, due to increased blood flow, and hence rapid clearance, from the operation site, particularly where the procedure is extensive, e.g. cancer surgery.32
  • Termination of Pregnancy - the standard guidance used to be to give antibiotic prophylaxis in all cases to prevent complications from pre-existing sexually-transmitted infection. However, recent work suggests that such precautions may not necessary providing patients are carefully screened.33 The BNF recommend a single dose of oral metronidazole, but give doxycycline if genital chlamydial infection cannot be ruled out.2 One trial suggests weak protection with metronidazole in patients with bacterial vaginosis, but larger randomised trials are needed.34 One trial using blanket cover for all patients with oral oxytetracycline and metronidazole suppositories reduced the rate of post-operative infection, presumably by treating undiagnosed bacterial vaginosis and chlamydia, and found that the cost-benefit of this approach was significant.35
Prevention of infection in vascular surgery
  • Reconstructive arterial surgery of abdomen, pelvis or legs - SIGN recommend antibiotic prophylaxis.23 The BNF advises a single dose of i/v cefuroxime or i/v gentamicin.
  • Additional intra-operative or postoperative doses may be necessary for lengthy procedures or if there is major blood loss.
  • For patients at risk of anaerobic infections (e.g. those with diabetes, gas gangrene, undergoing amputation), add i/v metronidazole.
  • Substitute i/v vancomycin for cefuroxime or gentamicin if there is a high risk of methicillin-resistant Staphylococcus aureus.2
  • There is some evidence that multiple doses regimes give better outcomes generally.36


Document references
  1. Elliott TS, Foweraker J, Gould FK, et al; Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.; J Antimicrob Chemother. 2004 Dec;54(6):971-81. Epub 2004 Nov 16. [abstract]
  2. British National Formulary British Medical Association and Royal Pharmaceutical Society of Great Britain. London.
  3. Gould FK, Elliott TS, Foweraker J, et al; Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy.; J Antimicrob Chemother. 2006 Jun;57(6):1035-42. Epub 2006 Apr 19. [abstract]
  4. Oliver R, Roberts GJ, Hooper L; Penicillins for the prophylaxis of bacterial endocarditis in dentistry.; Cochrane Database Syst Rev. 2004;(2):CD003813. [abstract]
  5. World Health Organisation; Streptococcal pharyngitis and prevention of rheumatic fever WHO Drug Information Vol. 14, No. 2, 2000
  6. Manyemba J, Mayosi BM; Penicillin for secondary prevention of rheumatic fever.; Cochrane Database Syst Rev. 2002;(3):CD002227. [abstract]
  7. Merck Manual: Rheumatic Fever
  8. Schaad UB; Chemoprophylaxis of bacterial meningitis. J Antimicrob Chemother. 1985 Feb;15(2):131-3.
  9. Clinical Evidence: Meningitis Prophylaxis; Needs registration
  10. Guidelines for public health management of meningococcal disease in the UK Working Group of the Public Health Laboratory Service Meningococcus Forum 2002
  11. The Green Book - immunisation against infectious diseases, Department of Health (various dates for individual immunisations)
  12. Dodhia H, Crowcroft NS, Bramley JC, et al; UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis.; J Public Health Med. 2002 Sep;24(3):200-6. [abstract]
  13. Price VE, Dutta S, Blanchette VS, et al; The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto.; Pediatr Blood Cancer. 2006 May 1;46(5):597-603. [abstract]
  14. Clinical Effectiveness; Sickle-Cell Disease 2004; Needs registration
  15. Gaston MH, Verter JI, Woods G, et al; Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.; N Engl J Med. 1986 Jun 19;314(25):1593-9. [abstract]
  16. Falletta JM, Woods GM, Verter JI, et al; Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.; J Pediatr. 1995 Nov;127(5):685-90. [abstract]
  17. Delahaye F, Hoen B, McFadden E, et al; Treatment and prevention of infective endocarditis.; Expert Opin Pharmacother. 2002 Feb;3(2):131-45. [abstract]
  18. Seymour RA, Whitworth JM, Martin M; Antibiotic prophylaxis for patients with joint prostheses - still a dilemma for dental practitioners.; Br Dent J. 2003 Jun 28;194(12):649-53. [abstract]
  19. Affleck AG, Birnie AJ, Gee TM, et al; Antibiotic prophylaxis in patients with valvular heart defects undergoing dermatological surgery remains a confusing issue despite apparently clear guidelines.; Clin Exp Dermatol. 2005 Sep;30(5):487-9. [abstract]
  20. Moller BN, Krebs B; Antibiotic prophylaxis in lower limb amputation.; Acta Orthop Scand. 1985 Aug;56(4):327-9. [abstract]
  21. No authors listed; Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society.; Thorax. 2000 Nov;55(11):887-901. [abstract]
  22. Smieja MJ, Marchetti CA, Cook DJ, et al; Isoniazid for preventing tuberculosis in non-HIV infected persons.; Cochrane Database Syst Rev. 2000;(2):CD001363. [abstract]
  23. Antibiotic Prophylaxis in Surgery; SIGN Guidance 45 2000; http://www.sign.ac.uk/guidelines/fulltext/45/summary.html
  24. Tocchi A, Lepre L, Costa G, et al; The need for antibiotic prophylaxis in elective laparoscopic cholecystectomy: a prospective randomized study.; Arch Surg. 2000 Jan;135(1):67-70; discussion 70. [abstract]
  25. Nichols RL, Choe EU, Weldon CB; Mechanical and antibacterial bowel preparation in colon and rectal surgery.; Chemotherapy. 2005;51 Suppl 1:115-21. [abstract]
  26. Nelson DB; Infection control during gastrointestinal endoscopy.; J Lab Clin Med. 2003 Mar;141(3):159-67. [abstract]
  27. Puig J, Darnell A, Bermudez P, et al; Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?; Eur Radiol. 2006 Apr;16(4):939-43. Epub 2006 Jan 4. [abstract]
  28. Valdevenito Sepulveda JP; ; Arch Esp Urol. 2004 Jan-Feb;57(1):48-57. [abstract]
  29. Christiano AP, Hollowell CM, Kim H, et al; Double-blind randomized comparison of single-dose ciprofloxacin versus intravenous cefazolin in patients undergoing outpatient endourologic surgery.; Urology. 2000 Feb;55(2):182-5. [abstract]
  30. Ahmed ET, Mirghani OA, Gerais AS, et al; Ceftriaxone versus ampicillin/cloxacillin as antibiotic prophylaxis in elective caesarean section.; East Mediterr Health J. 2004 May;10(3):277-88. [abstract]
  31. Thigpen BD, Hood WA, Chauhan S, et al; Timing of prophylactic antibiotic administration in the uninfected laboring gravida: a randomized clinical trial.; Am J Obstet Gynecol. 2005 Jun;192(6):1864-8; discussion 1868-71. [abstract]
  32. Bouma J, Dankert J; Infection after radical abdominal hysterectomy and pelvic lymphadenectomy: prevention of infection with a two-dose peri-operative antibiotic prophylaxis.; Int J Gynecol Cancer. 1993 Mar;3(2):94-102. [abstract]
  33. Uthayakumar S, Tenuwara W, Maiti H; Is it evidence-based practice? Prophylactic antibiotics for termination of pregnancy to minimize post-abortion pelvic infection? Int J STD AIDS. 2000 Mar;11(3):168-9. [abstract]
  34. Crowley T, Low N, Turner A, et al; Antibiotic prophylaxis to prevent post-abortal upper genital tract infection in women with bacterial vaginosis: randomised controlled trial.; BJOG. 2001 Apr;108(4):396-402. [abstract]
  35. Blackwell AL, Emery SJ, Thomas PD, et al; Universal prophylaxis for Chlamydia trachomatis and anaerobic vaginosis in women attending for suction termination of pregnancy: an audit of short-term health gains.; Int J STD AIDS. 1999 Aug;10(8):508-13. [abstract]
  36. Voesten HG, Degener JE, Dijkstra PK, et al; Optimizing antimicrobial prophylaxis in reconstructive vascular surgery.; Vasa. 1993;22(4):342-6. [abstract]

Internet and further reading AcknowledgementsEMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.
DocID: 512
Document Version: 2
DocRef: bgp25147
Last Updated: 2 Aug 2007
Review Date: 1 Aug 2008






















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page